Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.19 USD | -0.08% | +6.09% | +11.32% |
03-13 | Top Premarket Decliners | MT |
03-12 | JPMorgan Adjusts Price Target on iTeos Therapeutics to $27 From $29, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.32% | 438M | |
+2.97% | 108B | |
+10.21% | 104B | |
+1.57% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- ITOS Stock
- News iTeos Therapeutics, Inc.
- JPMorgan Cuts Price Target on iTeos Therapeutics to $29 From $32, Maintains Overweight Rating